Streetbeat News

TSVT

2seventy bio, Inc.

https://www.2seventybio.com

Industry

Biotechnology

2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.

Open

4.95

Mkt cap

255M

Volume

High

4.96

P/E Ratio

-2.70

52-wk high

5.99

Low

4.94

Div yield

N/A

52-wk low

2.29

Insider trading has been observed in three healthcare stocks: Impinj, Inc. (PI), 2seventy bio, Inc. (TSVT), and Healthcare Realty Trust Incorporated (HR). Impinj and Healthcare Realty Trust posted upbeat Q2 results, while 2seventy bio reported a narrower Q2 loss. The insiders' purchases may indicate confidence in the companies' prospects.

Portfolio Pulse from Lisa Levin

August 17, 2023 | 1:02 pm

The article lists the stocks that gained and lost the most during Tuesday's mid-day trading session. Notable gainers include Novo Integrated Sciences, Delcath Systems, and Tiziana Life Sciences, all of which saw significant jumps in their stock prices due to various positive developments. On the other hand, F45 Training Holdings, Design Therapeutics, and Galecto were among the biggest losers, with their stock prices falling due to various negative developments.

Portfolio Pulse from Lisa Levin

August 15, 2023 | 6:01 pm

Guggenheim analyst Kelsey Goodwin has maintained a 'Buy' rating on 2seventy bio (NASDAQ:TSVT), but lowered the price target from $27 to $26.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 3:34 pm

Despite a general downturn in the US stock market, several stocks recorded gains. Pharvaris N.V. surged 19.4% after an upgrade from Morgan Stanley. Paysafe Limited jumped 18.9% after reporting Q2 FY23 revenue growth of 6% YoY, beating consensus. Taylor Devices, Inc. surged 18.6% following Q4 results. Grindr Inc. jumped 10.7% after reporting YoY increase in Q2 sales. SomaLogic, Inc. gained 10.6% after reporting better-than-expected Q2 results and issuing guidance. NextDecade Corporation climbed 10.3% after an upgrade from Stifel. Humacyte, Inc. gained 9.2% after a reiteration from Benchmark. Riskified Ltd. rose 8.2% after posting upbeat quarterly sales and boosting FY23 revenue guidance.

Portfolio Pulse from Lisa Levin

August 15, 2023 | 2:43 pm

In the last quarter, 2seventy bio (NASDAQ:TSVT) received 5 analyst ratings, with 1 being bullish, 3 somewhat bullish, and 1 indifferent. The average price target is $22.0, representing an upside from the current price of $6.03. However, this average price target is a 16.98% decrease from the previous average price target of $26.50.

Portfolio Pulse from Benzinga Insights

August 15, 2023 | 1:00 pm

Goldman Sachs analyst Salveen Richter maintains a Buy rating on 2seventy bio (NASDAQ:TSVT) but lowers the price target from $27 to $24.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 12:41 pm

2seventy bio reported Q2 losses of $(0.83) per share, a 58.91% increase YoY. The company also reported $36.05M in sales, a 167.38% increase YoY.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 11:06 am

On Wednesday, 155 companies set new 52-week lows. The largest company by market cap to set a new 52-week low was Estee Lauder Cos (NYSE:EL). The smallest company by market cap to set a new 52-week low was SenesTech (NASDAQ:SNES). Siyata Mobile (NASDAQ:SYTA)'s stock fell the most, as it traded down 7658.62% to reach a new 52-week low. Sutro Biopharma (NASDAQ:STRO) was the biggest winner of the bunch, with shares actually trading up 0.0% after it rebounded from its new 52-week low.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 4:27 pm

On Monday, 149 companies reached new 52-week lows. The largest company by market cap to hit a new 52-week low was NextEra Energy (NYSE:NEE), while the smallest was Esports Entertainment (NASDAQ:GMBL). Bionano Genomics (NASDAQ:BNGO) saw the most pronounced move, with shares trading down 842.14% to hit its new 52-week low. Northwest Natural Hldg (NYSE:NWN) shares gained 0.0%, rebounding after it reached its 52-week low.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 4:13 pm

During Thursday's session, 92 stocks hit new 52-week lows. Pfizer was the biggest company on a market cap basis to set a new 52-week low. BitNile Metaverse was the smallest firm by market cap to set a new 52-week low. Aravive made the largest move down on the session, with shares plummeting 71.75% to reach its 52-week low. Senstar Tech saw the biggest bounce back on, as shares traded up 0.0% to rebound after it hit its new 52-week low.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 2:12 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.